SPALLUTO, Giampiero
 Distribuzione geografica
Continente #
NA - Nord America 2.104
AS - Asia 603
EU - Europa 523
AF - Africa 1
SA - Sud America 1
Totale 3.232
Nazione #
US - Stati Uniti d'America 2.095
CN - Cina 321
UA - Ucraina 163
TR - Turchia 133
SG - Singapore 112
DE - Germania 91
GB - Regno Unito 77
SE - Svezia 72
FI - Finlandia 43
IT - Italia 34
HK - Hong Kong 17
AT - Austria 13
CA - Canada 9
FR - Francia 7
JP - Giappone 7
IN - India 6
BE - Belgio 4
CZ - Repubblica Ceca 4
LT - Lituania 4
PL - Polonia 4
RU - Federazione Russa 4
IR - Iran 3
NL - Olanda 3
TW - Taiwan 3
BD - Bangladesh 1
MA - Marocco 1
PE - Perù 1
Totale 3.232
Città #
Chandler 241
Woodbridge 239
Houston 219
Fairfield 193
Jacksonville 187
Ann Arbor 150
Ashburn 94
Singapore 91
Nanjing 84
Wilmington 77
Izmir 72
Santa Clara 72
Beijing 66
Seattle 51
Cambridge 47
Princeton 44
Dearborn 35
Boardman 34
Shanghai 22
Shenyang 21
Nanchang 18
Hong Kong 17
San Diego 17
Addison 14
Milan 14
New York 13
San Mateo 13
Vienna 13
Changsha 12
Tianjin 11
Jiaxing 10
Hebei 9
Jinan 9
Los Angeles 9
Falls Church 8
Kunming 8
Norwalk 8
Bremen 7
Helsinki 7
Taizhou 7
London 6
Zhengzhou 6
Ningbo 5
Philadelphia 5
Toronto 5
Verona 5
Brussels 4
Ferrara 4
Munich 4
Olomouc 4
Des Moines 3
Düsseldorf 3
Lanzhou 3
Orange 3
Ottawa 3
Redwood City 3
Taipei 3
Urbana 3
Auburn Hills 2
Bielefeld 2
Cosenza 2
Haikou 2
Hiroshima 2
Kilburn 2
Kraskovo 2
Mountain View 2
Queens 2
Redmond 2
Taiyuan 2
Amsterdam 1
Ardabil 1
Arezzo 1
Augusta 1
Bangalore 1
Berlin 1
Casablanca 1
Chengdu 1
Clifton 1
Delhi 1
Durham 1
Edinburgh 1
Flensburg 1
Frankfurt am Main 1
Guangzhou 1
Hefei 1
Irvine 1
Leawood 1
Lima 1
Moscow 1
Mumbai 1
New Bedfont 1
New Delhi 1
Nottingham 1
Parma 1
Pasadena 1
Pune 1
San Francisco 1
Summerside 1
Tallahassee 1
Tappahannock 1
Totale 2.388
Nome #
4-Isopropyl-2-oxazolin-5-one anion as a new convenient formyl anion equivalent for conjugate addition and aldol reactions 201
A formal total synthesis (±)-forskolin through [3+2] nitrile oxide cycloaddition chemistry 145
Enantioselective synthesis of (-)-meroquinene through tandem Michael reaction methodology 144
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 142
4-Isopropyl-2-oxazolin-5-one anion as masked umpoled synthon for both formyl and hydroxycarbonyl anions: generation, reactivity and synthetic applications 128
MASTERING BETA-KETO-ESTERS 126
5-Hydroxytryptamine-mediated effects of nicotine on endogenous GABA efflux from guinea-pig cortical slices. 123
Changes in cortical ACh and GABA outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors 119
Effect of acute and subchronic nicotine treatment on cortical efflux of [3H]-D-aspartate and endogenous GABA in freely moving guinea-pigs. 116
Resolution of a CPzI precursor, synthesis and biological evaluation of (+) and (-)-N-Boc-CPzI: A further validation of the relationship between chemical solvolytic stability and cytotoxicity 107
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. 104
New potent and selective human adenosine A3 receptor antagonists 98
7-substituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: importance of modifications at the side chain on the activity and solubility. 96
Alpha-2 adrenoreceptor-mediated decrease in gamma-aminobutyric acid outflow in cortical slices and synaptosomes during morphine tolerance. 87
[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 86
Generation and cycloaddition reactions of 3-substituted-2-nitro-1,3- dienes 84
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 82
Alpha-1 adrenoreceptor-mediated increase in ACh release in brain slices during morphine tolerance 81
7-sobstituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonist: importance of modifications at the side chain on the activity and solubility. 80
Pyrazolo [4,3-E]1,2,4-triazolo[1,5-c]pyrimidine derivates a new class of potent and selective human A3 adenosine receptor antagonists. 79
[3H]MRE3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 78
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]-pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists 74
Synthesis, binding and thermodynamic studies of new highly selective A2A adenosine receptor antagonists 72
Synthesis and molecular investigation of new pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivates as human A3 adenosine receptor antagonists. 70
Synthesis and molecular investigation of new pyrazolo[4,3-e]1,2,4,-triazolo[1,5-c]pyrimidine derivates as human A3 adenosine receptor antagonists. 68
Pharmacological and biochemical characterization of A3 adenosine receptor in Jurkat T cells. 67
Synthesis and pharmacological characterization of [3H]-MRE3008F20: the first radioligand antagonist for the human A3 adenosine receptors. 62
Synthesis and preliminary biological evaluation of [3H]-MRE 3008F20: the first high affinity radioligand antagonist for the human A3 adenosine receptors 62
Pyrazolo-triazolo-pyrimidine derivates as adenosine receptor ligands: a search for A2B adenosine receptor antagonists. 61
Synthesis, biological properties and molecular modelling investigation of the first potent, selective and water soluble human A3 adenosine receptor antagonist. 61
Second generation of A2A adenosine receptor antagonist: synthesis and biological evaluation 61
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: A new pharmacological tool for the characterization of the human A(3) adenosine receptor 58
Pyrazolo [4,3-E]1,2,4-trazolo[1,5-c]pyrimidine derivatives a new class of potent and selective human A3 adenosine receptor antagonists 56
Pyrazolo-triazolo-pyrimidine as human A3 adenosine receptor antagonists: influence of the substitutent at N8 pyrazole nucleus. 54
Pyrazolo[4,3-e]1,2,4-triazolo[1,5]pyrimidine derivates as irreversible antagonists at the human A3 adenosine receptor 53
Fluorosulfonyl- and bis-(beta-chloroethyl)amino-phenylamino functionalized pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: Irreversible antagonists at the human A(3) adenosine receptor and molecular modeling studies 50
An efficient synthesis of 4-oxo-2,5-hexadienoates via Δ2-isoxazoline intermediates 13
Totale 3.248
Categoria #
all - tutte 14.646
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.646


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020389 0 0 0 0 47 64 66 53 38 90 22 9
2020/2021333 37 26 5 39 5 35 10 38 13 38 66 21
2021/2022375 9 40 18 26 19 10 11 21 15 30 44 132
2022/2023465 39 42 6 76 76 73 15 48 57 2 17 14
2023/2024193 21 24 10 5 27 26 8 11 5 3 1 52
2024/2025234 13 20 63 54 84 0 0 0 0 0 0 0
Totale 3.248